Niva Bupa Q3 FY26: 22% premium growth, swings to Rs 214 cr loss

Emphasis of matterNet loss reportedRevenue growth above 20%Results View source PDF Explain this filing

NIVABUPA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.2%Reaction day

₹78.02

prior close

₹76.00

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.9%+1.4% vs market

General Insurance peers, median of 5sector+1.4%+0.8% vs sector

On the reaction day the stock moved 1.4 pts more than Nifty Smallcap 250 and 0.8 pts more than its General Insurance peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.4

10m

+1.1

15m

+0.5

30m

+1.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.2+0.9+1.4+1.4+0.8

Next day

+1.5-0.8+2.3+0.3+1.2

+1.2+2.1-0.9+1.1+0.2

+0.7+2.9-2.2+1.6-0.9

-0.7+1.8-2.5+1.7-2.4

-0.6+1.5-2.0+2.1-2.7

+0.7+4.6-3.9+4.4-3.7

15d

-1.2+2.1-3.3+2.4-3.6

-5.8-0.3-5.5+2.0-7.8

-9.4-8.6-0.8-2.4-7.0

+0.7+7.0-6.3+5.5-4.7

UpDownMarket · Nifty Smallcap 250Sector · General Insurance peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Niva Bupa reported Q3 FY26 gross premiums of Rs. 2,231 crore, up about 55% YoY. Nine-month premiums grew 22% to Rs. 5,706 crore. However, it swung to a loss of about Rs. 88 crore in Q3 and Rs. 214 crore for nine months, against profits last year. Combined ratio worsened to 112% from 105%, and incurred claim ratio rose to about 74% from 63%. Solvency ratio fell to 2.49 from 3.03. Auditors flagged an emphasis of matter on the pending IRDAI approval for the company exceeding the allowed expenses of management limit.

Likely market impact

Widening underwriting losses, falling solvency, and emphasis of matter on pending IRDAI EOM approval may keep the stock under pressure.